CARE vs BCAL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CARE · Carter Bankshares$28.69 ▲ 0.74%
BCAL · California Bancorp$21.79 ▲ 0.79%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CARE +66.4%
- BCAL +17.1%
Head to head
| Metric | CARE | BCAL |
|---|---|---|
| Price | $28.69 | $21.79 |
| Change today | ▲ 0.74% | ▲ 0.79% |
| Market cap | $630.32M | $696.24M |
| Return, 3 months | -9.6% | +2.4% |
| Return, year to date | +46.9% | +18.6% |
| Return, 1 year | +65.6% | +18.2% |
| P/E (TTM) | 4.9 | 12.0 |
| P/B | 1.2 | 1.2 |
| P/E percentile vs own 5y | 0th | 65th |
| Dividend yield | 0.70% | 1.93% |
| Revenue growth (YoY, latest qtr) | +17.8% | +1.9% |
| Net profit growth (YoY) | +43.2% | -10.6% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 59.3% | 32.3% |
| Return on equity | 27.9% | 10.2% |
| Analyst target vs. price | +20.3% | +12.4% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 38 | 52 |
| 30-day volatility | 21.5% | 17.8% |
| Max drawdown, 1 year | -20.0% | -13.5% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BCAL is the largest of the group by market value.
- CARE has returned the most over the past year.
- CARE carries the lowest trailing P/E.
- BCAL pays the highest dividend yield.
- CARE is growing revenue fastest.
- CARE keeps the most profit per dollar of sales.
- BCAL has been the calmest stock over the last 30 days.